PI3K-话题@MedSci

#PI3K#

79篇内容 | 2644人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1333197, encodeId=21fb133319e07, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, objectTitle=CLIN CANCER RES：PI3K和BRAF联合抑制治疗晚期BRAF V600突变实体肿瘤, objectType=article, longId=125958, objectId=870a12595850, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=870a12595850, replyNumber=0, likeNumber=71, createdTime=2018-01-10, rootId=0, userName=ms1292405679162969, userId=7bb22500091, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=870a12595850, moduleTitle=CLIN CANCER RES：PI3K和BRAF联合抑制治疗晚期BRAF V600突变实体肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=870a12595850)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333196, encodeId=057d1333196f6, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, objectTitle=Sci Rep：硝酸益康唑抑制PI3K活性并促进肺癌细胞凋亡, objectType=article, longId=124575, objectId=feeb1245e5ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=feeb1245e5ec, replyNumber=0, likeNumber=83, createdTime=2017-12-27, rootId=0, userName=ms1292405679162969, userId=7bb22500091, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=feeb1245e5ec, moduleTitle=Sci Rep：硝酸益康唑抑制PI3K活性并促进肺癌细胞凋亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=feeb1245e5ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333195, encodeId=d060133319560, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, objectTitle=CLIN CANCER RES：AZD8186抑制PI3Kβ调节PTEN缺失肿瘤关键代谢通路, objectType=article, longId=124474, objectId=6cb61244e4be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cb61244e4be, replyNumber=0, likeNumber=62, createdTime=2017-12-26, rootId=0, userName=ms1292405679162969, userId=7bb22500091, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cb61244e4be, moduleTitle=CLIN CANCER RES：AZD8186抑制PI3Kβ调节PTEN缺失肿瘤关键代谢通路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cb61244e4be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333194, encodeId=9ed5133319418, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, objectTitle=Blood：PI3K-δ/γ抑制剂duvelisib用于T细胞淋巴瘤的活性。, objectType=article, longId=123385, objectId=165a123385bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=165a123385bf, replyNumber=0, likeNumber=57, createdTime=2017-12-15, rootId=0, userName=ms1292405679162969, userId=7bb22500091, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=165a123385bf, moduleTitle=Blood：PI3K-δ/γ抑制剂duvelisib用于T细胞淋巴瘤的活性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=165a123385bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333193, encodeId=16c813331930a, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, objectTitle=Blood：Duvelisib，一种新型的PI3K-δ和γ的口服抑制剂，对多种血液恶性肿瘤具有临床活性。, objectType=article, longId=122048, objectId=d42f12204853, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d42f12204853, replyNumber=0, likeNumber=97, createdTime=2017-12-03, rootId=0, userName=ms1292405679162969, userId=7bb22500091, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d42f12204853, moduleTitle=Blood：Duvelisib，一种新型的PI3K-δ和γ的口服抑制剂，对多种血液恶性肿瘤具有临床活性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d42f12204853)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333192, encodeId=e5f91333192bd, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, objectTitle=CLIN CANCER RES：PI3K通路作为膀胱癌的潜在治疗靶点, objectType=article, longId=119089, objectId=e13a119089cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e13a119089cc, replyNumber=0, likeNumber=82, createdTime=2017-11-09, rootId=0, userName=ms1292405679162969, userId=7bb22500091, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e13a119089cc, moduleTitle=CLIN CANCER RES：PI3K通路作为膀胱癌的潜在治疗靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e13a119089cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333191, encodeId=de5213331911c, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, objectTitle=CLIN CANCER RES：乳腺癌肝转移瘤PI3K-AKT-mTOR通路活性增强, objectType=article, longId=111287, objectId=b53211128e76, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b53211128e76, replyNumber=0, likeNumber=70, createdTime=2017-08-31, rootId=0, userName=ms1292405679162969, userId=7bb22500091, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b53211128e76, moduleTitle=CLIN CANCER RES：乳腺癌肝转移瘤PI3K-AKT-mTOR通路活性增强, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b53211128e76)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333190, encodeId=dcbc1333190de, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, objectTitle=Science：雌激素受体（ER）阳性乳腺癌抵抗PI3K抑制剂疗法的原因, objectType=article, longId=93347, objectId=0be19334e37, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0be19334e37, replyNumber=0, likeNumber=67, createdTime=2017-03-26, rootId=0, userName=ms1292405679162969, userId=7bb22500091, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0be19334e37, moduleTitle=Science：雌激素受体（ER）阳性乳腺癌抵抗PI3K抑制剂疗法的原因, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0be19334e37)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333189, encodeId=225c133318963, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, objectTitle=Clin Cancer Res：靶向治疗胰腺神经内分泌肿瘤新药物---PI3K蛋白, objectType=article, longId=71454, objectId=b075e1454ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b075e1454ee, replyNumber=0, likeNumber=63, createdTime=2016-06-24, rootId=0, userName=ms1292405679162969, userId=7bb22500091, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b075e1454ee, moduleTitle=Clin Cancer Res：靶向治疗胰腺神经内分泌肿瘤新药物---PI3K蛋白, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b075e1454ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333188, encodeId=d1221333188eb, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, objectTitle=BMC Cancer：EGFR/PI3K/PTEN轴与三阴乳腺癌预后间关系, objectType=article, longId=60952, objectId=b6376095204, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6376095204, replyNumber=0, likeNumber=74, createdTime=2015-12-23, rootId=0, userName=ms1292405679162969, userId=7bb22500091, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6376095204, moduleTitle=BMC Cancer：EGFR/PI3K/PTEN轴与三阴乳腺癌预后间关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6376095204)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333187, encodeId=b3d1133318e0d, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, objectTitle=Cell Reports：2型糖尿病胰岛素抵抗的新分子PI3K-C2α, objectType=article, longId=56336, objectId=349f56336b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=349f56336b2, replyNumber=0, likeNumber=77, createdTime=2015-09-20, rootId=0, userName=ms1292405679162969, userId=7bb22500091, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=349f56336b2, moduleTitle=Cell Reports：2型糖尿病胰岛素抵抗的新分子PI3K-C2α, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=349f56336b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333186, encodeId=424d1333186cb, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, objectTitle=PNAS：“救命药”竟成“夺命药”——PI3K抑制剂促进癌转移, objectType=article, longId=52908, objectId=67e952908da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67e952908da, replyNumber=0, likeNumber=65, createdTime=2015-07-07, rootId=0, userName=ms1292405679162969, userId=7bb22500091, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67e952908da, moduleTitle=PNAS：“救命药”竟成“夺命药”——PI3K抑制剂促进癌转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=67e952908da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333185, encodeId=715a1333185d1, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, objectTitle=Cancer Discov.：PI3K畸变致使鳞状细胞肺癌向脑转移, objectType=article, longId=50356, objectId=f1ca503565a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1ca503565a, replyNumber=0, likeNumber=69, createdTime=2015-05-08, rootId=0, userName=ms1292405679162969, userId=7bb22500091, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1ca503565a, moduleTitle=Cancer Discov.：PI3K畸变致使鳞状细胞肺癌向脑转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1ca503565a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333184, encodeId=ed99133318434, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, objectTitle=Nat Immuno：PI3K 信号通路控制调节性T细胞种群, objectType=article, longId=45686, objectId=4bb04568674, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bb04568674, replyNumber=0, likeNumber=62, createdTime=2015-01-21, rootId=0, userName=ms1292405679162969, userId=7bb22500091, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bb04568674, moduleTitle=Nat Immuno：PI3K 信号通路控制调节性T细胞种群, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4bb04568674)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333183, encodeId=294b13331834f, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, objectTitle=SABCS 2014：PI3K抑制剂用于ER阳性AI耐药的晚期乳腺癌, objectType=article, longId=44407, objectId=20064440e2c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20064440e2c, replyNumber=0, likeNumber=65, createdTime=2014-12-24, rootId=0, userName=ms1292405679162969, userId=7bb22500091, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20064440e2c, moduleTitle=SABCS 2014：PI3K抑制剂用于ER阳性AI耐药的晚期乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20064440e2c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333182, encodeId=a7ba1333182c3, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, objectTitle=Clin Cancer Res：PI3K靶向新药Pictilisib在进展期实体肿瘤病人中的I期临床试验, objectType=article, longId=42400, objectId=3e374240092, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e374240092, replyNumber=0, likeNumber=63, createdTime=2014-11-12, rootId=0, userName=ms1292405679162969, userId=7bb22500091, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e374240092, moduleTitle=Clin Cancer Res：PI3K靶向新药Pictilisib在进展期实体肿瘤病人中的I期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e374240092)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333181, encodeId=6bba13331810b, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, objectTitle=EB 2014：PI3K/mTOR特异性抑制剂BEZ235联合多柔比星可改善胰腺癌临床疗效, objectType=article, longId=35042, objectId=905535042f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=905535042f7, replyNumber=0, likeNumber=79, createdTime=2014-05-22, rootId=0, userName=ms1292405679162969, userId=7bb22500091, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=905535042f7, moduleTitle=EB 2014：PI3K/mTOR特异性抑制剂BEZ235联合多柔比星可改善胰腺癌临床疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=905535042f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333180, encodeId=b4dc1333180af, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, objectTitle=Science：PI3Kδ基因突变导致呼吸道感染复发的罕见遗传病, objectType=article, longId=26744, objectId=650f26e445c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=650f26e445c, replyNumber=0, likeNumber=95, createdTime=2013-11-21, rootId=0, userName=ms1292405679162969, userId=7bb22500091, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=650f26e445c, moduleTitle=Science：PI3Kδ基因突变导致呼吸道感染复发的罕见遗传病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=650f26e445c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333179, encodeId=523713331e9f9, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, objectTitle=Gastroenterology:PI3K抑制剂和5-氟尿嘧啶有不同疗效的胃癌分子亚型, objectType=article, longId=23917, objectId=0ae62391e12, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ae62391e12, replyNumber=0, likeNumber=79, createdTime=2013-09-07, rootId=0, userName=ms1292405679162969, userId=7bb22500091, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ae62391e12, moduleTitle=Gastroenterology:PI3K抑制剂和5-氟尿嘧啶有不同疗效的胃癌分子亚型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ae62391e12)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333178, encodeId=29b213331e8d5, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, objectTitle=PI3K抑制剂局部给药可防治急性肺损伤, objectType=article, longId=3162, objectId=f04331627e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f04331627e, replyNumber=0, likeNumber=97, createdTime=2011-10-11, rootId=0, userName=ms1292405679162969, userId=7bb22500091, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f04331627e, moduleTitle=PI3K抑制剂局部给药可防治急性肺损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f04331627e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

PI3K

2020-05-29

ms1292405679162969 (审核中...)

前往app查看评论内容

#PI3K#

CLIN CANCER RES：PI3K和BRAF联合抑制治疗晚期BRAF V600突变实体肿瘤

2018-01-10

ms1292405679162969 (审核中...)

前往app查看评论内容

#PI3K#

Sci Rep：硝酸益康唑抑制PI3K活性并促进肺癌细胞凋亡

2017-12-27

ms1292405679162969 (审核中...)

前往app查看评论内容

#PI3K#

CLIN CANCER RES：AZD8186抑制PI3Kβ调节PTEN缺失肿瘤关键代谢通路

2017-12-26

ms1292405679162969 (审核中...)

前往app查看评论内容

#PI3K#

Blood：PI3K-δ/γ抑制剂duvelisib用于T细胞淋巴瘤的活性。

2017-12-15

ms1292405679162969 (审核中...)

前往app查看评论内容

#PI3K#

Blood：Duvelisib，一种新型的PI3K-δ和γ的口服抑制剂，对多种血液恶性肿瘤具有临床活性。

2017-12-03

ms1292405679162969 (审核中...)

前往app查看评论内容

#PI3K#

CLIN CANCER RES：PI3K通路作为膀胱癌的潜在治疗靶点

2017-11-09

ms1292405679162969 (审核中...)

前往app查看评论内容

#PI3K#

CLIN CANCER RES：乳腺癌肝转移瘤PI3K-AKT-mTOR通路活性增强

2017-08-31

ms1292405679162969 (审核中...)

前往app查看评论内容

#PI3K#

Science：雌激素受体（ER）阳性乳腺癌抵抗PI3K抑制剂疗法的原因

2017-03-26

ms1292405679162969 (审核中...)

前往app查看评论内容

#PI3K#

Clin Cancer Res：靶向治疗胰腺神经内分泌肿瘤新药物---PI3K蛋白

2016-06-24

ms1292405679162969 (审核中...)

前往app查看评论内容

#PI3K#

BMC Cancer：EGFR/PI3K/PTEN轴与三阴乳腺癌预后间关系

2015-12-23

ms1292405679162969 (审核中...)

前往app查看评论内容

#PI3K#

Cell Reports：2型糖尿病胰岛素抵抗的新分子PI3K-C2α

2015-09-20

ms1292405679162969 (审核中...)

前往app查看评论内容

#PI3K#

PNAS：“救命药”竟成“夺命药”——PI3K抑制剂促进癌转移

2015-07-07

ms1292405679162969 (审核中...)

前往app查看评论内容

#PI3K#

Cancer Discov.：PI3K畸变致使鳞状细胞肺癌向脑转移

2015-05-08

ms1292405679162969 (审核中...)

前往app查看评论内容

#PI3K#

Nat Immuno：PI3K 信号通路控制调节性T细胞种群

2015-01-21

ms1292405679162969 (审核中...)

前往app查看评论内容

#PI3K#

SABCS 2014：PI3K抑制剂用于ER阳性AI耐药的晚期乳腺癌

2014-12-24

ms1292405679162969 (审核中...)

前往app查看评论内容

#PI3K#

Clin Cancer Res：PI3K靶向新药Pictilisib在进展期实体肿瘤病人中的I期临床试验

2014-11-12

ms1292405679162969 (审核中...)

前往app查看评论内容

#PI3K#

EB 2014：PI3K/mTOR特异性抑制剂BEZ235联合多柔比星可改善胰腺癌临床疗效

2014-05-22

ms1292405679162969 (审核中...)

前往app查看评论内容

#PI3K#

Science：PI3Kδ基因突变导致呼吸道感染复发的罕见遗传病

2013-11-21

ms1292405679162969 (审核中...)

前往app查看评论内容

#PI3K#

Gastroenterology:PI3K抑制剂和5-氟尿嘧啶有不同疗效的胃癌分子亚型

2013-09-07

ms1292405679162969 (审核中...)

前往app查看评论内容

#PI3K#

PI3K抑制剂局部给药可防治急性肺损伤

2011-10-11

科室
- - 订阅+
  - 更多科室
工具
服务